Amundi
GILD icon

Amundi’s Gilead Sciences GILD Stock Holding History

Amundi’s Portfolio GILD Stock Details GILD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$1.47B Buy
10,539,111
+1,018,976
+11% +$143M 0.4% 43
2025
Q4 		$1.17B Buy
9,520,135
+1,936,354
+26% +$235M 0.32% 66
2025
Q3 		$861M Sell
7,583,781
-2,883,630
-28% -$328M 0.28% 70
2025
Q2 		$1.17B Buy
10,467,411
+1,614,355
+18% +$172M 0.4% 47
2025
Q1 		$995M Sell
8,853,056
-167,143
-2% -$17.2M 0.36% 54
2024
Q4 		$805M Sell
9,020,199
-4,596,188
-34% -$414M 0.28% 78
2024
Q3 		$1.16B Buy
13,616,387
+2,375,858
+21% +$181M 0.43% 46
2024
Q2 		$751M Buy
11,240,529
+1,739,913
+18% +$116M 0.29% 75
2024
Q1 		$640M Sell
9,500,616
-1,019,938
-10% -$78.4M 0.28% 83
2023
Q4 		$896M Sell
10,520,554
-82,104
-0.8% -$6.39M 0.4% 47
2023
Q3 		$818M Sell
10,602,658
-316,824
-3% -$24.4M 0.4% 45
2023
Q2 		$838M Buy
10,919,482
+294,400
+3% +$23.5M 0.42% 42
2023
Q1 		$888M Buy
10,625,082
+437,302
+4% +$36.2M 0.48% 38
2022
Q4 		$886M Sell
10,187,780
-21,368
-0.2% -$1.69M 0.49% 35
2022
Q3 		$659M Buy
10,209,148
+2,126,205
+26% +$134M 0.39% 45
2022
Q2 		$500M Buy
8,082,943
+1,267,513
+19% +$78.5M 0.4% 52
2022
Q1 		$412M Sell
6,815,430
-4,123,846
-38% -$264M 0.28% 92
2021
Q4 		$788M Buy
10,939,276
+495,760
+5% +$34.1M 0.5% 39
2021
Q3 		$729M Buy
10,443,516
+1,617,865
+18% +$114M 0.51% 36
2021
Q2 		$608M Buy
+8,825,651
New +$589M 0.42% 47

Other funds holding GILD

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Amundi's GILD Position: Q1 2026 in Review

Amundi increased its Gilead Sciences (GILD) stake by 11% in Q1 2026, buying an estimated $143M and bringing the position to 10,539,111 shares worth $1.47B. The position accounts for 0.4% of the portfolio, ranked #43.

Amundi first reported a position in GILD in Q2 2021 and has held it in 20 quarters since. 2,309 funds tracked by Wall St. Rank hold GILD as of Q1 2026.

  • Amundi held 10,539,111 shares of Gilead Sciences worth $1.47B as of Q1 2026.
  • Amundi bought 1,018,976 Gilead Sciences shares in Q1 2026, an estimated $143M.
  • Gilead Sciences made up 0.4% of Amundi's portfolio in Q1 2026, its #43 holding.
  • Amundi first reported a position in Gilead Sciences in Q2 2021 and has held it in 20 quarters since.
  • 2,309 funds tracked by Wall St. Rank held Gilead Sciences as of Q1 2026.

Based on Amundi's 13F filing for Q1 2026, filed 18 May 2026.